TP53 and cancer: This effect of differential somatic TP53 mutation rate obviously does not exist in Li-Fraumeni patients who have a germline mutation in TP53, which may explain why they differ from sporadic cancer cases with respect to the association of SNP309 with the age at cancer onset.